Aarti Pharmalabs Limited
AARTIPHARM.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$77.58B
Close$
$-465.42
155.9% downside
Current Fair Value
155.9% downsideOvervalued by 155.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $77.58 Billion |
|---|---|
| Enterprise Value | $77.58 Billion |
| Dividend Yield | $3.50 (0.41%) |
| Earnings per Share | $19.27 |
| Beta | 0.23 |
| Outstanding Shares | 90,646,071 |
Return
| Return on Equity | 10.03% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 36.39 |
|---|---|
| PEG | 67.61 |
| Price to Sales | 3.84 |
| Price to Book Ratio | 3.56 |
| Enterprise Value to Revenue | 3.94 |
| Enterprise Value to EBIT | 22.96 |
| Enterprise Value to Net Income | 36 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Aarti Pharmalabs Limited
2,421 employees
CEO: Hetal Gala Aarti Pharmalabs Limited, headquartered in Mumbai, India, and established in 2019 (originally Aarti Organics Limited), primarily focuses on the production and global distribution of active pharmaceutical ingredients (APIs) and pharmaceut...